Form D · Biotechnology
Avotres Inc.
Hanover, NJ · CIK 0001841331
Offering snapshot reported May 4, 2023 · SEC filing
- Reported sold
- $4M Offering amount: $4.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2023 | Initial | $4,000,000 | No comparison | 3 | SEC filing |
| Feb 24, 2021 | Initial | $4,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-480794
Source: Form D, filed May 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jihong Chen | Director |
| Bruce Cooper | Director |
| Biao He | Director |
| John Houghton | Executive |
| Hong Jiang | Director |
| Yan Lei | Director |
| Alex Li | Director |
| Xi Qin | Director |
| Zhongping Sun | Director |
| Dan Zhao | Director |
| Zihao Zou | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
140 East Hanover Ave., Ste. 140
Hanover, NJ, 07927
Hanover, NJ, 07927